Side Effect;Report Count;Proportion
VOMITING;359;0.09184
NAUSEA;356;0.09107
PAIN;356;0.09107
PYREXIA;292;0.07470
DYSPNOEA;286;0.07316
HEADACHE;266;0.06805
OFF LABEL USE;264;0.06754
ABDOMINAL PAIN;258;0.06600
GENERAL PHYSICAL HEALTH DETERIORATION;234;0.05986
ANAEMIA;228;0.05833
ARTHRALGIA;227;0.05807
DRUG INEFFECTIVE;227;0.05807
SOMNOLENCE;221;0.05654
DIARRHOEA;212;0.05423
FATIGUE;208;0.05321
SEPSIS;200;0.05116
MALAISE;199;0.05091
PAIN IN EXTREMITY;194;0.04963
CONSTIPATION;185;0.04733
ASTHENIA;182;0.04656
ABDOMINAL DISTENSION;169;0.04323
ASCITES;159;0.04068
HYPERTENSION;159;0.04068
CONDITION AGGRAVATED;157;0.04016
HYPONATRAEMIA;157;0.04016
PNEUMONIA;156;0.03991
DIZZINESS;154;0.03940
STRESS;147;0.03761
GAIT DISTURBANCE;145;0.03709
WEIGHT DECREASED;142;0.03633
MULTIPLE ORGAN DYSFUNCTION SYNDROME;135;0.03454
APPENDICITIS;134;0.03428
URINARY TRACT INFECTION;133;0.03402
CARDIOGENIC SHOCK;132;0.03377
FALL;132;0.03377
INFLUENZA;132;0.03377
SWELLING;132;0.03377
APPENDICOLITH;131;0.03351
DRUG HYPERSENSITIVITY;128;0.03274
VENTRICULAR FIBRILLATION;128;0.03274
DRY MOUTH;125;0.03198
PRURITUS;121;0.03095
BACK PAIN;119;0.03044
COUGH;118;0.03019
DIABETES MELLITUS;118;0.03019
BLOOD CHOLESTEROL INCREASED;117;0.02993
PULMONARY EMBOLISM;116;0.02968
DRUG INTERACTION;115;0.02942
DEATH;113;0.02891
BLOOD PHOSPHORUS INCREASED;109;0.02788
THROMBOSIS;107;0.02737
PRODUCT USE IN UNAPPROVED INDICATION;103;0.02635
HYPOTENSION;100;0.02558
TACHYCARDIA;97;0.02481
HYPERSENSITIVITY;96;0.02456
INSOMNIA;95;0.02430
BACTERIAL INFECTION;94;0.02405
BLOOD URIC ACID INCREASED;94;0.02405
PERIPHERAL SWELLING;93;0.02379
ERYTHEMA;91;0.02328
INTENTIONAL PRODUCT MISUSE;91;0.02328
SLEEP DISORDER;90;0.02302
DECREASED APPETITE;87;0.02226
MYASTHENIA GRAVIS;84;0.02149
NEURALGIA;83;0.02123
WEIGHT INCREASED;83;0.02123
ABDOMINAL PAIN UPPER;82;0.02098
RASH;82;0.02098
TREMOR;80;0.02047
DEPRESSION;79;0.02021
DRUG INTOLERANCE;77;0.01970
ANAPHYLACTIC REACTION;75;0.01919
CHRONIC OBSTRUCTIVE PULMONARY DISEASE;75;0.01919
CHEST PAIN;73;0.01867
RHEUMATOID ARTHRITIS;73;0.01867
INCORRECT ROUTE OF PRODUCT ADMINISTRATION;71;0.01816
MEMORY IMPAIRMENT;71;0.01816
ACUTE KIDNEY INJURY;69;0.01765
HYPOPHOSPHATAEMIA;67;0.01714
IRON DEFICIENCY;66;0.01688
ANXIETY;65;0.01663
HYPERPHOSPHATAEMIA;65;0.01663
MUSCULAR WEAKNESS;64;0.01637
OEDEMA PERIPHERAL;63;0.01612
RENAL FAILURE;63;0.01612
FEBRILE NEUTROPENIA;62;0.01586
BLOOD PRESSURE INCREASED;61;0.01561
INFECTION;61;0.01561
ASPARTATE AMINOTRANSFERASE INCREASED;60;0.01535
CONFUSIONAL STATE;60;0.01535
FEELING ABNORMAL;60;0.01535
PLEURAL EFFUSION;60;0.01535
SEPTIC SHOCK;60;0.01535
HYPERHIDROSIS;59;0.01509
HYPOAESTHESIA;58;0.01484
CHILLS;57;0.01458
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION;54;0.01381
JOINT SWELLING;53;0.01356
INJECTION SITE PAIN;52;0.01330
OSTEOARTHRITIS;52;0.01330
CARDIAC ARREST;51;0.01305
COVID-19;51;0.01305
IMMUNODEFICIENCY;51;0.01305
NASOPHARYNGITIS;51;0.01305
RESPIRATORY FAILURE;51;0.01305
VISUAL IMPAIRMENT;51;0.01305
NEUTROPENIA;50;0.01279
THROMBOCYTOPENIA;50;0.01279
ALANINE AMINOTRANSFERASE INCREASED;49;0.01254
DEHYDRATION;49;0.01254
MUSCLE SPASMS;49;0.01254
MUSCULOSKELETAL STIFFNESS;49;0.01254
OVERDOSE;49;0.01254
SYNCOPE;49;0.01254
ANGIOEDEMA;48;0.01228
MOBILITY DECREASED;48;0.01228
MYALGIA;48;0.01228
URTICARIA;48;0.01228
ARRHYTHMIA;47;0.01202
CARDIAC FAILURE;47;0.01202
ALOPECIA;46;0.01177
ANALGESIC THERAPY;46;0.01177
BLOOD PRESSURE DECREASED;46;0.01177
ARTHROPATHY;45;0.01151
CEREBROVASCULAR ACCIDENT;45;0.01151
SLEEP DISORDER THERAPY;45;0.01151
DRUG THERAPY;44;0.01126
TOXIC EPIDERMAL NECROLYSIS;44;0.01126
AGRANULOCYTOSIS;43;0.01100
NECK PAIN;43;0.01100
AGITATION;42;0.01074
INFLAMMATION;42;0.01074
PARAESTHESIA;42;0.01074
MYOCARDIAL INFARCTION;41;0.01049
SUICIDE ATTEMPT;41;0.01049
LEUKOPENIA;40;0.01023
OROPHARYNGEAL PAIN;40;0.01023
PLATELET COUNT DECREASED;40;0.01023
PRODUCT DOSE OMISSION ISSUE;40;0.01023
GASTRITIS;39;0.00998
OXYGEN SATURATION DECREASED;39;0.00998
RENAL FAILURE ACUTE;39;0.00998
SPEECH DISORDER;39;0.00998
SPINAL PAIN;39;0.00998
ARTHRITIS;38;0.00972
NERVOUSNESS;38;0.00972
SINUSITIS;38;0.00972
HAEMORRHAGE;37;0.00947
MULTIPLE SCLEROSIS RELAPSE;37;0.00947
STEVENS-JOHNSON SYNDROME;37;0.00947
CATARACT;36;0.00921
LUNG DISORDER;36;0.00921
MALIGNANT NEOPLASM PROGRESSION;35;0.00895
PANCYTOPENIA;35;0.00895
DYSSTASIA;34;0.00870
SEIZURE;34;0.00870
SKIN DISCOLOURATION;34;0.00870
ULCER;34;0.00870
BLISTER;33;0.00844
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;33;0.00844
LIVER DISORDER;33;0.00844
MUSCULOSKELETAL PAIN;33;0.00844
ATRIAL FIBRILLATION;32;0.00819
BURNING SENSATION;32;0.00819
CARDIAC DISORDER;32;0.00819
FOETAL EXPOSURE DURING PREGNANCY;32;0.00819
COLITIS;31;0.00793
GAIT INABILITY;31;0.00793
RENAL DISORDER;31;0.00793
TOXICITY TO VARIOUS AGENTS;31;0.00793
VISION BLURRED;31;0.00793
GASTROOESOPHAGEAL REFLUX DISEASE;30;0.00767
PRODUCT USE ISSUE;30;0.00767
RHINORRHOEA;30;0.00767
WOUND;30;0.00767
BLOOD CREATININE INCREASED;29;0.00742
DYSPHAGIA;29;0.00742
GOUT;29;0.00742
BONE PAIN;28;0.00716
C-REACTIVE PROTEIN INCREASED;28;0.00716
DRY SKIN;28;0.00716
HYPOTHYROIDISM;28;0.00716
INFUSION RELATED REACTION;28;0.00716
INTERVERTEBRAL DISC PROTRUSION;28;0.00716
CARDIO-RESPIRATORY ARREST;27;0.00691
CHOLELITHIASIS;27;0.00691
COMA;27;0.00691
DECREASED IMMUNE RESPONSIVENESS;27;0.00691
EPISTAXIS;27;0.00691
FEELING HOT;27;0.00691
HEART RATE INCREASED;27;0.00691
HEPATIC FAILURE;27;0.00691
LOSS OF CONSCIOUSNESS;27;0.00691
BLOOD PRESSURE FLUCTUATION;26;0.00665
HAEMOGLOBIN DECREASED;26;0.00665
NEPHROLITHIASIS;26;0.00665
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED;25;0.00640
BLOOD GLUCOSE INCREASED;25;0.00640
DEPRESSED LEVEL OF CONSCIOUSNESS;25;0.00640
DISEASE PROGRESSION;25;0.00640
DRUG-INDUCED LIVER INJURY;25;0.00640
LONG QT SYNDROME;25;0.00640
MATERNAL EXPOSURE DURING PREGNANCY;25;0.00640
RESPIRATORY DISORDER;25;0.00640
URINARY INCONTINENCE;25;0.00640
ABDOMINAL DISCOMFORT;24;0.00614
ANAESTHETIC COMPLICATION NEUROLOGICAL;24;0.00614
CHEST DISCOMFORT;24;0.00614
CROHN^S DISEASE;24;0.00614
CRYING;24;0.00614
DISORIENTATION;24;0.00614
FEMUR FRACTURE;24;0.00614
GAMMA-GLUTAMYLTRANSFERASE INCREASED;24;0.00614
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION;24;0.00614
JAUNDICE;24;0.00614
MULTIPLE SCLEROSIS;24;0.00614
RENAL IMPAIRMENT;24;0.00614
SHOCK;24;0.00614
TYPE I HYPERSENSITIVITY;24;0.00614
ASTHMA;23;0.00588
BRADYCARDIA;23;0.00588
EXPOSURE DURING PREGNANCY;23;0.00588
HAEMATOMA;23;0.00588
HOSPITALISATION;23;0.00588
IRRITABILITY;23;0.00588
METABOLIC ACIDOSIS;23;0.00588
MOVEMENT DISORDER;23;0.00588
MUCOSAL INFLAMMATION;23;0.00588
PRODUCT AVAILABILITY ISSUE;23;0.00588
SKIN EXFOLIATION;23;0.00588
ANGINA PECTORIS;22;0.00563
AORTIC STENOSIS;22;0.00563
DENGUE FEVER;22;0.00563
DYSPHONIA;22;0.00563
DYSPNOEA EXERTIONAL;22;0.00563
HAEMATEMESIS;22;0.00563
HAEMATURIA;22;0.00563
HYPERLIPIDAEMIA;22;0.00563
INFLUENZA LIKE ILLNESS;22;0.00563
INJECTION SITE ERYTHEMA;22;0.00563
OSTEOPOROSIS;22;0.00563
PULMONARY CONGESTION;22;0.00563
ANAPHYLACTIC SHOCK;21;0.00537
DEPRESSED MOOD;21;0.00537
DYSPEPSIA;21;0.00537
HYPOPHAGIA;21;0.00537
INCORRECT DOSE ADMINISTERED;21;0.00537
RASH MACULAR;21;0.00537
SKIN LESION;21;0.00537
SWELLING FACE;21;0.00537
CONVULSION;20;0.00512
CROSS SENSITIVITY REACTION;20;0.00512
DEEP VEIN THROMBOSIS;20;0.00512
DELIRIUM;20;0.00512
DISCOMFORT;20;0.00512
DYSGEUSIA;20;0.00512
DYSURIA;20;0.00512
GASTROINTESTINAL DISORDER;20;0.00512
HERPES ZOSTER;20;0.00512
HYPERTENSIVE CRISIS;20;0.00512
HYPOKALAEMIA;20;0.00512
HYPOXIA;20;0.00512
LUNG INFECTION;20;0.00512
MULTI-ORGAN FAILURE;20;0.00512
OEDEMA;20;0.00512
PALPITATIONS;20;0.00512
VIRAL INFECTION;20;0.00512
ABASIA;19;0.00486
DEVICE RELATED INFECTION;19;0.00486
END STAGE RENAL DISEASE;19;0.00486
FEEDING DISORDER;19;0.00486
FIBROMYALGIA;19;0.00486
HAEMOPTYSIS;19;0.00486
HEPATIC STEATOSIS;19;0.00486
INTENTIONAL OVERDOSE;19;0.00486
LIMB DISCOMFORT;19;0.00486
MIGRAINE;19;0.00486
MOTOR DYSFUNCTION;19;0.00486
MUSCULOSKELETAL DISORDER;19;0.00486
PRODUCTIVE COUGH;19;0.00486
PULMONARY OEDEMA;19;0.00486
RESTLESSNESS;19;0.00486
RHINITIS;19;0.00486
THROAT IRRITATION;19;0.00486
BALANCE DISORDER;18;0.00460
BRONCHITIS;18;0.00460
CENTRAL NERVOUS SYSTEM LESION;18;0.00460
CYANOSIS;18;0.00460
DEAFNESS;18;0.00460
DRUG DEPENDENCE;18;0.00460
HALLUCINATION;18;0.00460
IMPAIRED HEALING;18;0.00460
PSORIASIS;18;0.00460
THERAPY INTERRUPTED;18;0.00460
TROPONIN INCREASED;18;0.00460
ADVERSE EVENT;17;0.00435
ANTACID THERAPY;17;0.00435
CARDIOVASCULAR DISORDER;17;0.00435
CHOLECYSTITIS;17;0.00435
CLOSTRIDIUM DIFFICILE COLITIS;17;0.00435
COAGULOPATHY;17;0.00435
DRUG DOSE OMISSION;17;0.00435
EATING DISORDER;17;0.00435
FINGER DEFORMITY;17;0.00435
HEPATOMEGALY;17;0.00435
HYPERAEMIA;17;0.00435
LIMB INJURY;17;0.00435
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES;17;0.00435
ORAL CANDIDIASIS;17;0.00435
PHARYNGITIS;17;0.00435
RESPIRATORY DISTRESS;17;0.00435
VERTIGO;17;0.00435
WHEEZING;17;0.00435
ABORTION SPONTANEOUS;16;0.00409
ANTICOAGULANT THERAPY;16;0.00409
BEDRIDDEN;16;0.00409
BONE DISORDER;16;0.00409
CYTOMEGALOVIRUS INFECTION;16;0.00409
DISTURBANCE IN ATTENTION;16;0.00409
ERYSIPELAS;16;0.00409
EYE PAIN;16;0.00409
EYE SWELLING;16;0.00409
HERPES VIRUS INFECTION;16;0.00409
LEUKOCYTOSIS;16;0.00409
NERVOUS SYSTEM DISORDER;16;0.00409
PALLOR;16;0.00409
PANCREATITIS;16;0.00409
PRURITUS GENERALISED;16;0.00409
STOMATITIS;16;0.00409
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS;16;0.00409
BONE MARROW FAILURE;15;0.00384
BRONCHOSPASM;15;0.00384
CONJUNCTIVITIS;15;0.00384
EMOTIONAL DISTRESS;15;0.00384
FRACTURE;15;0.00384
GASTRITIS EROSIVE;15;0.00384
HAEMATOCHEZIA;15;0.00384
HYPOKINESIA;15;0.00384
ILL-DEFINED DISORDER;15;0.00384
ILLNESS;15;0.00384
OSTEOMYELITIS;15;0.00384
PETECHIAE;15;0.00384
PRODUCT PRESCRIBING ERROR;15;0.00384
ACUTE MYOCARDIAL INFARCTION;14;0.00358
BLOOD PRESSURE ABNORMAL;14;0.00358
COMPLETED SUICIDE;14;0.00358
DRUG ADMINISTRATION ERROR;14;0.00358
FEAR;14;0.00358
FEELING COLD;14;0.00358
FOOT DEFORMITY;14;0.00358
HEAD DISCOMFORT;14;0.00358
LIVER INJURY;14;0.00358
MENTAL DISORDER;14;0.00358
METASTASES TO LIVER;14;0.00358
MUSCLE ATROPHY;14;0.00358
NEOPLASM MALIGNANT;14;0.00358
OLIGOHYDRAMNIOS;14;0.00358
PELVIC PAIN;14;0.00358
PNEUMONITIS;14;0.00358
POLYNEUROPATHY;14;0.00358
PROCEDURAL PAIN;14;0.00358
RHABDOMYOLYSIS;14;0.00358
SNEEZING;14;0.00358
STAPHYLOCOCCAL INFECTION;14;0.00358
TRICUSPID VALVE INCOMPETENCE;14;0.00358
TUBERCULOSIS;14;0.00358
ANKYLOSING SPONDYLITIS;13;0.00333
APHASIA;13;0.00333
BACTEROIDES INFECTION;13;0.00333
BLINDNESS;13;0.00333
BRONCHOPNEUMONIA;13;0.00333
CELLULITIS;13;0.00333
CHROMATURIA;13;0.00333
DRUG ERUPTION;13;0.00333
EMOTIONAL DISORDER;13;0.00333
FUNGAL INFECTION;13;0.00333
GASTRIC ULCER;13;0.00333
GASTROENTERITIS;13;0.00333
HEPATITIS;13;0.00333
HEPATOTOXICITY;13;0.00333
HYPOGLYCAEMIA;13;0.00333
LEFT VENTRICULAR DYSFUNCTION;13;0.00333
METASTASES TO BONE;13;0.00333
NASAL CONGESTION;13;0.00333
OESOPHAGITIS;13;0.00333
PERICARDIAL EFFUSION;13;0.00333
PERITONITIS;13;0.00333
PROTEINURIA;13;0.00333
SENSORY DISTURBANCE;13;0.00333
SEROTONIN SYNDROME;13;0.00333
SYSTEMIC LUPUS ERYTHEMATOSUS;13;0.00333
THERAPEUTIC PRODUCT EFFECT INCOMPLETE;13;0.00333
TINNITUS;13;0.00333
UPPER GASTROINTESTINAL HAEMORRHAGE;13;0.00333
WHITE BLOOD CELL COUNT DECREASED;13;0.00333
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS;12;0.00307
AORTIC VALVE INCOMPETENCE;12;0.00307
BLOOD CHOLESTEROL ABNORMAL;12;0.00307
BLOOD LACTATE DEHYDROGENASE INCREASED;12;0.00307
BUNDLE BRANCH BLOCK LEFT;12;0.00307
CATARRH;12;0.00307
DERMATITIS;12;0.00307
DERMATITIS ALLERGIC;12;0.00307
DIVERTICULITIS;12;0.00307
FLUSHING;12;0.00307
GOITRE;12;0.00307
HEPATIC CIRRHOSIS;12;0.00307
HEPATIC ENZYME INCREASED;12;0.00307
HYPERGLYCAEMIA;12;0.00307
HYPERTHYROIDISM;12;0.00307
INGUINAL HERNIA;12;0.00307
INTENTIONAL PRODUCT USE ISSUE;12;0.00307
INTERNATIONAL NORMALISED RATIO INCREASED;12;0.00307
JOINT DISLOCATION;12;0.00307
JOINT STIFFNESS;12;0.00307
LACRIMATION INCREASED;12;0.00307
LARYNGEAL OEDEMA;12;0.00307
NEUROPATHY PERIPHERAL;12;0.00307
NODULE;12;0.00307
OSTEONECROSIS;12;0.00307
PANIC ATTACK;12;0.00307
POLLAKIURIA;12;0.00307
PSEUDOMONAS INFECTION;12;0.00307
PULMONARY HYPERTENSION;12;0.00307
PULMONARY MASS;12;0.00307
RESPIRATORY DEPRESSION;12;0.00307
SPINAL DISORDER;12;0.00307
SURGERY;12;0.00307
TACHYPNOEA;12;0.00307
THROAT TIGHTNESS;12;0.00307
TREATMENT FAILURE;12;0.00307
VAGINAL HAEMORRHAGE;12;0.00307
AGEUSIA;11;0.00281
AMNESIA;11;0.00281
ASPHYXIA;11;0.00281
ASPIRATION;11;0.00281
BLOOD ALKALINE PHOSPHATASE INCREASED;11;0.00281
CHOKING;11;0.00281
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR;11;0.00281
DISCOURAGEMENT;11;0.00281
EAR PAIN;11;0.00281
ENCEPHALOPATHY;11;0.00281
ERYTHEMA MULTIFORME;11;0.00281
GASTRIC DISORDER;11;0.00281
GLAUCOMA;11;0.00281
HEAD INJURY;11;0.00281
HEMIPARESIS;11;0.00281
HIATUS HERNIA;11;0.00281
HYPERKALAEMIA;11;0.00281
INTESTINAL HAEMORRHAGE;11;0.00281
JOINT INJURY;11;0.00281
JOINT RANGE OF MOTION DECREASED;11;0.00281
LOCALISED INFECTION;11;0.00281
MITRAL VALVE INCOMPETENCE;11;0.00281
OCULAR HYPERAEMIA;11;0.00281
PANIC DISORDER;11;0.00281
PNEUMONIA ASPIRATION;11;0.00281
POOR QUALITY SLEEP;11;0.00281
RASH ERYTHEMATOUS;11;0.00281
RESPIRATORY TRACT INFECTION;11;0.00281
SKIN DISORDER;11;0.00281
SKIN ULCER;11;0.00281
THERAPEUTIC RESPONSE DECREASED;11;0.00281
UNEVALUABLE EVENT;11;0.00281
UPPER LIMB FRACTURE;11;0.00281
URINARY RETENTION;11;0.00281
VARICOSE VEIN;11;0.00281
VASCULITIS;11;0.00281
WRONG TECHNIQUE IN DRUG USAGE PROCESS;11;0.00281
APHTHOUS ULCER;10;0.00256
APPLICATION SITE PAIN;10;0.00256
ATROPHY;10;0.00256
BLOOD BILIRUBIN INCREASED;10;0.00256
BLOOD CREATINE PHOSPHOKINASE INCREASED;10;0.00256
BLOOD UREA INCREASED;10;0.00256
CHOLESTASIS;10;0.00256
CHONDROPATHY;10;0.00256
COGNITIVE DISORDER;10;0.00256
CONCOMITANT DISEASE AGGRAVATED;10;0.00256
CONTUSION;10;0.00256
COORDINATION ABNORMAL;10;0.00256
DERMATITIS BULLOUS;10;0.00256
ECZEMA;10;0.00256
ELECTROCARDIOGRAM QT PROLONGED;10;0.00256
EYE DISORDER;10;0.00256
FLUID RETENTION;10;0.00256
GASTROINTESTINAL HAEMORRHAGE;10;0.00256
GASTROINTESTINAL NEOPLASM;10;0.00256
HAEMORRHOIDAL HAEMORRHAGE;10;0.00256
IMMUNE SYSTEM DISORDER;10;0.00256
INJURY;10;0.00256
INTESTINAL PERFORATION;10;0.00256
LUNG NEOPLASM MALIGNANT;10;0.00256
MALNUTRITION;10;0.00256
MASS;10;0.00256
MOUTH ULCERATION;10;0.00256
MYOCLONUS;10;0.00256
POST PROCEDURAL COMPLICATION;10;0.00256
PRODUCT QUALITY ISSUE;10;0.00256
PULMONARY FIBROSIS;10;0.00256
QUALITY OF LIFE DECREASED;10;0.00256
RASH MACULO-PAPULAR;10;0.00256
RETCHING;10;0.00256
SUICIDAL IDEATION;10;0.00256
TENDONITIS;10;0.00256
WHITE BLOOD CELL COUNT INCREASED;10;0.00256
ACUTE RESPIRATORY FAILURE;9;0.00230
ANAL FISSURE;9;0.00230
APHONIA;9;0.00230
ASTHMATIC CRISIS;9;0.00230
BACTERAEMIA;9;0.00230
BLOOD POTASSIUM DECREASED;9;0.00230
BLOOD TRIGLYCERIDES INCREASED;9;0.00230
BODY HEIGHT DECREASED;9;0.00230
BRAIN OEDEMA;9;0.00230
CACHEXIA;9;0.00230
CARDIAC DYSFUNCTION;9;0.00230
CARDIOMEGALY;9;0.00230
CATHETER SITE INFECTION;9;0.00230
COLON NEOPLASM;9;0.00230
CYSTITIS;9;0.00230
DRUG ABUSE;9;0.00230
DRUG EFFECT INCOMPLETE;9;0.00230
DRUG EXPOSURE DURING PREGNANCY;9;0.00230
DRY EYE;9;0.00230
EPILEPSY;9;0.00230
EXOSTOSIS;9;0.00230
EYE IRRITATION;9;0.00230
EYELID OEDEMA;9;0.00230
FLATULENCE;9;0.00230
FLUID INTAKE REDUCED;9;0.00230
GASTROINTESTINAL INFECTION;9;0.00230
GASTROINTESTINAL PAIN;9;0.00230
GRAND MAL CONVULSION;9;0.00230
HEPATIC ENCEPHALOPATHY;9;0.00230
HOT FLUSH;9;0.00230
INJECTION SITE HAEMATOMA;9;0.00230
INTESTINAL OBSTRUCTION;9;0.00230
KIDNEY INFECTION;9;0.00230
LYMPHADENOPATHY;9;0.00230
MELAENA;9;0.00230
MUSCULOSKELETAL CHEST PAIN;9;0.00230
MYOCARDITIS;9;0.00230
ODYNOPHAGIA;9;0.00230
OLIGURIA;9;0.00230
OROPHARYNGEAL DISCOMFORT;9;0.00230
PEMPHIGOID;9;0.00230
PHARYNGEAL INFLAMMATION;9;0.00230
PYELONEPHRITIS;9;0.00230
RALES;9;0.00230
RECTAL HAEMORRHAGE;9;0.00230
RENAL PAIN;9;0.00230
RESPIRATORY ARREST;9;0.00230
RHINITIS ALLERGIC;9;0.00230
SECRETION DISCHARGE;9;0.00230
SERUM FERRITIN INCREASED;9;0.00230
SKIN IRRITATION;9;0.00230
SPINAL OSTEOARTHRITIS;9;0.00230
SUDDEN DEATH;9;0.00230
SUPRAVENTRICULAR TACHYCARDIA;9;0.00230
TRANSAMINASES INCREASED;9;0.00230
UPPER RESPIRATORY TRACT INFECTION;9;0.00230
VENTRICULAR EXTRASYSTOLES;9;0.00230
ABDOMINAL PAIN LOWER;8;0.00205
ABORTION INDUCED;8;0.00205
ACNE;8;0.00205
ACUTE HEPATIC FAILURE;8;0.00205
ACUTE RESPIRATORY DISTRESS SYNDROME;8;0.00205
ADENOMA BENIGN;8;0.00205
ADVERSE DRUG REACTION;8;0.00205
ANKLE FRACTURE;8;0.00205
ANOSMIA;8;0.00205
APATHY;8;0.00205
ATELECTASIS;8;0.00205
BLINDNESS UNILATERAL;8;0.00205
BLOOD GLUCOSE DECREASED;8;0.00205
BODY FAT DISORDER;8;0.00205
BONE DENSITY DECREASED;8;0.00205
BRONCHOPULMONARY ASPERGILLOSIS;8;0.00205
CATHETER SITE INFLAMMATION;8;0.00205
CIRCULATORY COLLAPSE;8;0.00205
COLD SWEAT;8;0.00205
CYTOKINE RELEASE SYNDROME;8;0.00205
DEVICE MALFUNCTION;8;0.00205
DUCTUS ARTERIOSUS PREMATURE CLOSURE;8;0.00205
DYSARTHRIA;8;0.00205
DYSENTERY;8;0.00205
DYSPNOEA AT REST;8;0.00205
EPIDERMOLYSIS;8;0.00205
FACIAL PAIN;8;0.00205
FISTULA;8;0.00205
FLANK PAIN;8;0.00205
FOOT FRACTURE;8;0.00205
GAMMOPATHY;8;0.00205
GASTROINTESTINAL DYSPLASIA;8;0.00205
GASTROINTESTINAL INFLAMMATION;8;0.00205
GASTROINTESTINAL TRACT ADENOMA;8;0.00205
GENERALISED OEDEMA;8;0.00205
HERNIA;8;0.00205
HYPERBILIRUBINAEMIA;8;0.00205
HYPOALBUMINAEMIA;8;0.00205
HYPOTHERMIA;8;0.00205
INCORRECT ROUTE OF DRUG ADMINISTRATION;8;0.00205
INJECTION SITE MASS;8;0.00205
INJECTION SITE PRURITUS;8;0.00205
LABYRINTHITIS;8;0.00205
LACTIC ACIDOSIS;8;0.00205
LIPASE INCREASED;8;0.00205
METASTASIS;8;0.00205
MIDDLE INSOMNIA;8;0.00205
MUSCULOSKELETAL DISCOMFORT;8;0.00205
OBESITY;8;0.00205
OBSTRUCTIVE SLEEP APNOEA SYNDROME;8;0.00205
OSTEOPENIA;8;0.00205
PARALYSIS;8;0.00205
PATHOLOGICAL FRACTURE;8;0.00205
PNEUMONIA BACTERIAL;8;0.00205
PNEUMOTHORAX;8;0.00205
PRESCRIBED UNDERDOSE;8;0.00205
PRESYNCOPE;8;0.00205
PSYCHOMOTOR HYPERACTIVITY;8;0.00205
RENAL CYST;8;0.00205
SINONASAL OBSTRUCTION;8;0.00205
SKIN LACERATION;8;0.00205
SLUGGISHNESS;8;0.00205
SPINAL FRACTURE;8;0.00205
SYNOVITIS;8;0.00205
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;8;0.00205
THERAPEUTIC RESPONSE UNEXPECTED;8;0.00205
THERAPY NON-RESPONDER;8;0.00205
TOOTH DISORDER;8;0.00205
TRACHEAL DISORDER;8;0.00205
TRACHEOBRONCHITIS;8;0.00205
TRANSPLANT REJECTION;8;0.00205
TREATMENT NONCOMPLIANCE;8;0.00205
WALDENSTROM^S MACROGLOBULINAEMIA;8;0.00205
WOUND INFECTION;8;0.00205
ACUTE ABDOMEN;7;0.00179
ACUTE PULMONARY OEDEMA;7;0.00179
AGGRESSION;7;0.00179
ALTERED STATE OF CONSCIOUSNESS;7;0.00179
APPLICATION SITE ERYTHEMA;7;0.00179
AUTOIMMUNE HEPATITIS;7;0.00179
BLOOD GLUCOSE ABNORMAL;7;0.00179
BLOOD TEST ABNORMAL;7;0.00179
BLOOD URINE PRESENT;7;0.00179
CARDIAC FAILURE CONGESTIVE;7;0.00179
CEREBRAL HAEMORRHAGE;7;0.00179
CHIKUNGUNYA VIRUS INFECTION;7;0.00179
CHOLECYSTITIS CHRONIC;7;0.00179
COLITIS ULCERATIVE;7;0.00179
CONGENITAL CARDIOVASCULAR ANOMALY;7;0.00179
CORONARY ARTERY DISEASE;7;0.00179
DEVELOPMENTAL HIP DYSPLASIA;7;0.00179
DILATED CARDIOMYOPATHY;7;0.00179
DRUG LEVEL INCREASED;7;0.00179
DRUG WITHDRAWAL SYNDROME;7;0.00179
DRY THROAT;7;0.00179
EJECTION FRACTION DECREASED;7;0.00179
EMPHYSEMA;7;0.00179
ESCHERICHIA BACTERAEMIA;7;0.00179
FREQUENT BOWEL MOVEMENTS;7;0.00179
GALLBLADDER DISORDER;7;0.00179
GLUCOSE TOLERANCE IMPAIRED;7;0.00179
HAEMARTHROSIS;7;0.00179
HAND DEFORMITY;7;0.00179
HYPERAESTHESIA;7;0.00179
HYPOACUSIS;7;0.00179
HYPOMAGNESAEMIA;7;0.00179
HYPOTONIA;7;0.00179
ILEUS PARALYTIC;7;0.00179
INFARCTION;7;0.00179
INJECTION SITE DISCOLOURATION;7;0.00179
INJECTION SITE NECROSIS;7;0.00179
LICHENOID KERATOSIS;7;0.00179
LIGAMENT SPRAIN;7;0.00179
LIP OEDEMA;7;0.00179
LOWER RESPIRATORY TRACT INFECTION;7;0.00179
LUNG OPACITY;7;0.00179
LYMPHOMA;7;0.00179
MEDICATION ERROR;7;0.00179
MENISCUS INJURY;7;0.00179
MENORRHAGIA;7;0.00179
METABOLIC SYNDROME;7;0.00179
METASTASES TO SPINE;7;0.00179
MOUTH HAEMORRHAGE;7;0.00179
MULTIPLE DRUG OVERDOSE INTENTIONAL;7;0.00179
MYOCARDIAL NECROSIS MARKER INCREASED;7;0.00179
OBSTRUCTIVE AIRWAYS DISORDER;7;0.00179
OESOPHAGEAL CANDIDIASIS;7;0.00179
ORAL HERPES;7;0.00179
PANCREATITIS ACUTE;7;0.00179
PELVIC FRACTURE;7;0.00179
PERIPHERAL COLDNESS;7;0.00179
PHLEBITIS;7;0.00179
PNEUMONIA KLEBSIELLA;7;0.00179
POISONING;7;0.00179
PREMATURE DELIVERY;7;0.00179
PRODUCT STORAGE ERROR;7;0.00179
PULMONARY SEPSIS;7;0.00179
RECTAL NEOPLASM;7;0.00179
RENAL TUBULAR NECROSIS;7;0.00179
SKIN BURNING SENSATION;7;0.00179
SKIN FISSURES;7;0.00179
SMALL INTESTINE ADENOCARCINOMA;7;0.00179
SPHINCTER OF ODDI DYSFUNCTION;7;0.00179
SWOLLEN TONGUE;7;0.00179
TENDON RUPTURE;7;0.00179
TONSILLITIS;7;0.00179
TOTAL LUNG CAPACITY DECREASED;7;0.00179
TUBULOINTERSTITIAL NEPHRITIS;7;0.00179
UNRESPONSIVE TO STIMULI;7;0.00179
UROSEPSIS;7;0.00179
VENTRICULAR ARRHYTHMIA;7;0.00179
VENTRICULAR ENLARGEMENT;7;0.00179
VITAMIN D DECREASED;7;0.00179
WEIGHT FLUCTUATION;7;0.00179
ABNORMAL FAECES;6;0.00153
ACCIDENT;6;0.00153
ACTIVITIES OF DAILY LIVING IMPAIRED;6;0.00153
ACUTE CORONARY SYNDROME;6;0.00153
ANAL HAEMORRHAGE;6;0.00153
ANURIA;6;0.00153
APNOEA;6;0.00153
ATAXIA;6;0.00153
BLOOD PRESSURE INADEQUATELY CONTROLLED;6;0.00153
BODY TEMPERATURE INCREASED;6;0.00153
BURSITIS;6;0.00153
CARDIOMYOPATHY;6;0.00153
CARTILAGE INJURY;6;0.00153
CHRONIC SINUSITIS;6;0.00153
CLOSTRIDIUM DIFFICILE INFECTION;6;0.00153
COVID-19 PNEUMONIA;6;0.00153
CUTANEOUS VASCULITIS;6;0.00153
CYST;6;0.00153
CYSTITIS HAEMORRHAGIC;6;0.00153
DEFORMITY;6;0.00153
DEMENTIA;6;0.00153
DIPLOPIA;6;0.00153
DRUG EFFECT DECREASED;6;0.00153
DYSKINESIA;6;0.00153
ELECTROLYTE IMBALANCE;6;0.00153
ENDOCARDITIS;6;0.00153
ENTEROCOCCAL INFECTION;6;0.00153
EOSINOPHILIA;6;0.00153
EYE PRURITUS;6;0.00153
FACE OEDEMA;6;0.00153
FACIAL PARESIS;6;0.00153
FEMORAL NECK FRACTURE;6;0.00153
FORMICATION;6;0.00153
FURUNCLE;6;0.00153
GALLBLADDER POLYP;6;0.00153
GASTRIC HAEMORRHAGE;6;0.00153
GASTRIC ULCER HAEMORRHAGE;6;0.00153
GENERAL PHYSICAL CONDITION ABNORMAL;6;0.00153
GRAFT VERSUS HOST DISEASE;6;0.00153
HAEMATOCRIT DECREASED;6;0.00153
HAEMORRHAGIC STROKE;6;0.00153
HALLUCINATION, VISUAL;6;0.00153
HEART RATE DECREASED;6;0.00153
HEPATITIS CHOLESTATIC;6;0.00153
HIP ARTHROPLASTY;6;0.00153
HYPERCALCAEMIA;6;0.00153
ILEUS;6;0.00153
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;6;0.00153
INCREASED UPPER AIRWAY SECRETION;6;0.00153
INTESTINAL STENOSIS;6;0.00153
ISCHAEMIA;6;0.00153
ISCHAEMIC STROKE;6;0.00153
JOINT EFFUSION;6;0.00153
LICHEN PLANUS;6;0.00153
LIVER FUNCTION TEST INCREASED;6;0.00153
LOWER LIMB FRACTURE;6;0.00153
MEGACOLON;6;0.00153
METASTASES TO CENTRAL NERVOUS SYSTEM;6;0.00153
METASTASES TO LUNG;6;0.00153
METASTASES TO LYMPH NODES;6;0.00153
METASTATIC RENAL CELL CARCINOMA;6;0.00153
NEOPLASM PROGRESSION;6;0.00153
NOSOCOMIAL INFECTION;6;0.00153
OVARIAN CYST;6;0.00153
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME;6;0.00153
PHOTOSENSITIVITY REACTION;6;0.00153
PLATELET DYSFUNCTION;6;0.00153
POST PROCEDURAL HAEMORRHAGE;6;0.00153
POSTOPERATIVE WOUND INFECTION;6;0.00153
PROCEDURAL COMPLICATION;6;0.00153
PRODUCT DOSE OMISSION;6;0.00153
PSEUDOMEMBRANOUS COLITIS;6;0.00153
PSYCHOTIC DISORDER;6;0.00153
PURULENCE;6;0.00153
QUADRIPARESIS;6;0.00153
RED BLOOD CELL COUNT DECREASED;6;0.00153
ROAD TRAFFIC ACCIDENT;6;0.00153
SENSORY LOSS;6;0.00153
SICKLE CELL ANAEMIA WITH CRISIS;6;0.00153
SKIN HAEMORRHAGE;6;0.00153
SKIN INFECTION;6;0.00153
SKIN MASS;6;0.00153
SOPOR;6;0.00153
SPUTUM DISCOLOURED;6;0.00153
SUDDEN CARDIAC DEATH;6;0.00153
TENSION;6;0.00153
THERAPEUTIC PRODUCT CROSS-REACTIVITY;6;0.00153
THROMBOPHLEBITIS;6;0.00153
TIBIA FRACTURE;6;0.00153
TRACHEITIS;6;0.00153
TRUNCUS ARTERIOSUS PERSISTENT;6;0.00153
UMBILICAL HERNIA;6;0.00153
UNDERDOSE;6;0.00153
UTERINE LEIOMYOMA;6;0.00153
UVEITIS;6;0.00153
VENTRICULAR SEPTAL DEFECT;6;0.00153
VISUAL ACUITY REDUCED;6;0.00153
VITAMIN D DEFICIENCY;6;0.00153
WRIST FRACTURE;6;0.00153
YELLOW SKIN;6;0.00153
ABDOMINAL WOUND DEHISCENCE;5;0.00128
ABSCESS;5;0.00128
ACCIDENTAL OVERDOSE;5;0.00128
ACIDOSIS;5;0.00128
AFFECTIVE DISORDER;5;0.00128
ANAL FISTULA;5;0.00128
ANOREXIA;5;0.00128
ARTERIAL OCCLUSIVE DISEASE;5;0.00128
AZOTAEMIA;5;0.00128
BLOOD CREATININE ABNORMAL;5;0.00128
BLOOD SODIUM DECREASED;5;0.00128
BRAIN INJURY;5;0.00128
BREAST CANCER;5;0.00128
BRONCHIOLITIS;5;0.00128
C-REACTIVE PROTEIN ABNORMAL;5;0.00128
CANDIDA INFECTION;5;0.00128
CANDIDIASIS;5;0.00128
CATHETER SITE INJURY;5;0.00128
CEREBRAL DISORDER;5;0.00128
CEREBRAL ISCHAEMIA;5;0.00128
CEREBRAL VASOCONSTRICTION;5;0.00128
CORONARY ARTERY OCCLUSION;5;0.00128
DELUSION;5;0.00128
DIARRHOEA HAEMORRHAGIC;5;0.00128
DRUG PRESCRIBING ERROR;5;0.00128
EAR DISCOMFORT;5;0.00128
EROSIVE OESOPHAGITIS;5;0.00128
EYE DISCHARGE;5;0.00128
FAECALOMA;5;0.00128
GINGIVAL PAIN;5;0.00128
GRIP STRENGTH DECREASED;5;0.00128
HAEMODIALYSIS;5;0.00128
HEART DISEASE CONGENITAL;5;0.00128
HEART RATE ABNORMAL;5;0.00128
HEPATIC CANCER;5;0.00128
HEPATIC FUNCTION ABNORMAL;5;0.00128
HUMERUS FRACTURE;5;0.00128
HYDROCEPHALUS;5;0.00128
HYPERCHOLESTEROLAEMIA;5;0.00128
HYPERTHERMIA;5;0.00128
HYPERVENTILATION;5;0.00128
HYPOAESTHESIA ORAL;5;0.00128
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME;5;0.00128
IMMUNE-MEDIATED HEPATITIS;5;0.00128
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED;5;0.00128
INJECTION SITE BRUISING;5;0.00128
LABORATORY TEST ABNORMAL;5;0.00128
LARYNGOSPASM;5;0.00128
LETHARGY;5;0.00128
LEUKAEMIA;5;0.00128
LIMB MASS;5;0.00128
LIP SWELLING;5;0.00128
LUMBAR VERTEBRAL FRACTURE;5;0.00128
LUNG NEOPLASM;5;0.00128
MECHANICAL VENTILATION;5;0.00128
MICTURITION URGENCY;5;0.00128
MIOSIS;5;0.00128
MOUTH INJURY;5;0.00128
MYOPIA;5;0.00128
NAIL DISORDER;5;0.00128
NASAL PRURITUS;5;0.00128
NECROSIS;5;0.00128
NEOPLASM;5;0.00128
NEUROGENIC BLADDER;5;0.00128
NEUROTOXICITY;5;0.00128
NEUTROPHIL COUNT DECREASED;5;0.00128
ORAL PAIN;5;0.00128
ORTHOSTATIC HYPOTENSION;5;0.00128
OSTEOLYSIS;5;0.00128
PAIN OF SKIN;5;0.00128
PARKINSON^S DISEASE;5;0.00128
PERITONEAL PERFORATION;5;0.00128
POST PROCEDURAL HAEMATOMA;5;0.00128
POST PROCEDURAL INFECTION;5;0.00128
POSTPARTUM SEPSIS;5;0.00128
PREMATURE BABY;5;0.00128
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION;5;0.00128
PROCEDURAL HAEMORRHAGE;5;0.00128
PRODUCT ADMINISTRATION ERROR;5;0.00128
PRODUCT SUPPLY ISSUE;5;0.00128
PSORIATIC ARTHROPATHY;5;0.00128
PULMONARY HAEMORRHAGE;5;0.00128
RASH GENERALISED;5;0.00128
RASH PAPULAR;5;0.00128
RASH PRURITIC;5;0.00128
RESPIRATORY ALKALOSIS;5;0.00128
SCIATICA;5;0.00128
SINUS TACHYCARDIA;5;0.00128
SKIN PAPILLOMA;5;0.00128
SOCIAL PROBLEM;5;0.00128
SPINAL OPERATION;5;0.00128
SUSPECTED COVID-19;5;0.00128
SYNOVIAL CYST;5;0.00128
TENDON DISORDER;5;0.00128
THERAPY PARTIAL RESPONDER;5;0.00128
TONGUE DISORDER;5;0.00128
TOOTH EXTRACTION;5;0.00128
VENOUS THROMBOSIS;5;0.00128
WITHDRAWAL SYNDROME;5;0.00128
ABDOMINAL HERNIA;4;0.00102
ACARODERMATITIS;4;0.00102
ADMINISTRATION RELATED REACTION;4;0.00102
ADRENAL INSUFFICIENCY;4;0.00102
ALLERGIC COUGH;4;0.00102
AMENORRHOEA;4;0.00102
ANAEMIA POSTOPERATIVE;4;0.00102
ANAL INCONTINENCE;4;0.00102
ANGER;4;0.00102
ANTICHOLINERGIC SYNDROME;4;0.00102
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC;4;0.00102
ARTHROPOD BITE;4;0.00102
BLOOD CALCIUM DECREASED;4;0.00102
BLOOD CALCIUM INCREASED;4;0.00102
BLOOD CREATINE INCREASED;4;0.00102
BLOOD DISORDER;4;0.00102
BLOOD IRON DECREASED;4;0.00102
BLOOD THYROID STIMULATING HORMONE INCREASED;4;0.00102
BONE EROSION;4;0.00102
BRADYARRHYTHMIA;4;0.00102
BREAST CANCER METASTATIC;4;0.00102
BRONCHIAL CARCINOMA;4;0.00102
BRONCHIECTASIS;4;0.00102
CANCER PAIN;4;0.00102
CARDIAC SEPTAL DEFECT;4;0.00102
CERVICAL VERTEBRAL FRACTURE;4;0.00102
CHOLANGITIS;4;0.00102
COAGULATION TEST ABNORMAL;4;0.00102
COMPLICATION ASSOCIATED WITH DEVICE;4;0.00102
DEAFNESS UNILATERAL;4;0.00102
DERMATITIS EXFOLIATIVE;4;0.00102
DEVICE FAILURE;4;0.00102
DIABETES MELLITUS INADEQUATE CONTROL;4;0.00102
DISEASE RECURRENCE;4;0.00102
DIVERTICULUM INTESTINAL;4;0.00102
DRUG ABUSER;4;0.00102
DRUG TOXICITY;4;0.00102
DUODENAL ULCER HAEMORRHAGE;4;0.00102
DYSPLASIA;4;0.00102
EAR PRURITUS;4;0.00102
ELECTROCARDIOGRAM ABNORMAL;4;0.00102
ELECTROCARDIOGRAM CHANGE;4;0.00102
ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY;4;0.00102
ENCEPHALITIS;4;0.00102
EPSTEIN-BARR VIRUS INFECTION;4;0.00102
EXPIRED PRODUCT ADMINISTERED;4;0.00102
EYE INFLAMMATION;4;0.00102
FACIAL BONES FRACTURE;4;0.00102
FAECES DISCOLOURED;4;0.00102
FIXED ERUPTION;4;0.00102
FOOT OPERATION;4;0.00102
FUNCTIONAL GASTROINTESTINAL DISORDER;4;0.00102
GASTROINTESTINAL NECROSIS;4;0.00102
GENERAL SYMPTOM;4;0.00102
GROIN PAIN;4;0.00102
H1N1 INFLUENZA;4;0.00102
HAEMORRHOIDS;4;0.00102
HEART RATE IRREGULAR;4;0.00102
HEMIPLEGIA;4;0.00102
HEPATIC LESION;4;0.00102
HEPATIC NECROSIS;4;0.00102
HEPATITIS ACUTE;4;0.00102
HEPATOCELLULAR DAMAGE;4;0.00102
HEPATOSPLENOMEGALY;4;0.00102
HIP FRACTURE;4;0.00102
HYPERKERATOSIS;4;0.00102
HYPOCALCAEMIA;4;0.00102
HYPOPROTEINAEMIA;4;0.00102
HYPOVENTILATION;4;0.00102
HYPOVITAMINOSIS;4;0.00102
HYPOVOLAEMIC SHOCK;4;0.00102
HYSTERECTOMY;4;0.00102
IMMUNOSUPPRESSION;4;0.00102
INCORRECT PRODUCT ADMINISTRATION DURATION;4;0.00102
INFREQUENT BOWEL MOVEMENTS;4;0.00102
INJECTION SITE NODULE;4;0.00102
INJECTION SITE SWELLING;4;0.00102
INTENTIONAL DOSE OMISSION;4;0.00102
INTERVERTEBRAL DISCITIS;4;0.00102
KNEE ARTHROPLASTY;4;0.00102
KNEE OPERATION;4;0.00102
LEFT VENTRICULAR FAILURE;4;0.00102
LEG AMPUTATION;4;0.00102
LIP EROSION;4;0.00102
